{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:32:18Z","timestamp":1791167538206,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T00:00:00Z","timestamp":1354233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T00:00:00Z","timestamp":1354233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep00910","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T10:05:48Z","timestamp":1354269948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Age-dependent \u03b1-synuclein aggregation in the Microcebus murinus lemur primate"],"prefix":"10.1038","volume":"2","author":[{"given":"Marie-H\u00e9l\u00e8ne","family":"Canron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Perret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"B\u00e9zard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Dehay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,30]]},"reference":[{"key":"BFsrep00910_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s11910-008-0045-7","volume":"8","author":"DJ Moore","year":"2008","unstructured":"Moore, D. J. & Dawson, T. M. Value of genetic models in understanding the cause and mechanisms of Parkinson's disease. Curr Neurol Neurosci Rep 8, 288\u2013296 (2008).","journal-title":"Curr Neurol Neurosci Rep"},{"key":"BFsrep00910_CR2","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1002\/ana.21489","volume":"64","author":"P Jenner","year":"2008","unstructured":"Jenner, P. Functional models of Parkinson's disease: a valuable tool in the development of novel therapies. Ann Neurol 64 Suppl 2, S16\u201329 (2008).","journal-title":"Ann Neurol"},{"key":"BFsrep00910_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00401-008-0350-x","volume":"115","author":"GE Meredith","year":"2008","unstructured":"Meredith, G. E., Sonsalla, P. K. & Chesselet, M. F. Animal models of Parkinson's disease progression. Acta Neuropathol 115, 385\u2013398 (2008).","journal-title":"Acta Neuropathol"},{"key":"BFsrep00910_CR4","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/mds.23546","volume":"26","author":"B Dehay","year":"2011","unstructured":"Dehay, B. & Bezard, E. New animal models of Parkinson's disease. Mov Disord 26, 1198\u20131205 (2011).","journal-title":"Mov Disord"},{"key":"BFsrep00910_CR5","doi-asserted-by":"crossref","unstructured":"Bezard, E., Yue, Z., Kirik, D. & Spillantini, M. G. Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies. Mov Disord (2012).","DOI":"10.1002\/mds.25108"},{"key":"BFsrep00910_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/ilar.52.1.89","volume":"52","author":"SN Austad","year":"2011","unstructured":"Austad, S. N. & Fischer, K. E. The development of small primate models for aging research. ILAR J 52, 78\u201388 (2011).","journal-title":"ILAR J"},{"key":"BFsrep00910_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.arr.2011.07.001","volume":"11","author":"S Languille","year":"2012","unstructured":"Languille, S. et al. The grey mouse lemur: a non-human primate model for ageing studies. Ageing Res Rev 11, 150\u2013162 (2012).","journal-title":"Ageing Res Rev"},{"key":"BFsrep00910_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1601-183X.2005.00149.x","volume":"5","author":"N Bons","year":"2006","unstructured":"Bons, N., Rieger, F., Prudhomme, D., Fisher, A. & Krause, K. H. Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease? Genes Brain Behav 5, 120\u2013130 (2006).","journal-title":"Genes Brain Behav"},{"key":"BFsrep00910_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0197-4580(92)90016-Q","volume":"13","author":"N Bons","year":"1992","unstructured":"Bons, N., Mestre, N. & Petter, A. Senile plaques and neurofibrillary changes in the brain of an aged lemurian primate, Microcebus murinus. Neurobiol Aging 13, 99\u2013105 (1992).","journal-title":"Neurobiol Aging"},{"key":"BFsrep00910_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0197-4580(94)90115-5","volume":"15","author":"N Bons","year":"1994","unstructured":"Bons, N. et al. Identification of amyloid beta protein in the brain of the small, short-lived lemurian primate Microcebus murinus. Neurobiol Aging 15, 215\u2013220 (1994).","journal-title":"Neurobiol Aging"},{"key":"BFsrep00910_CR11","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.neurobiolaging.2009.05.018","volume":"32","author":"A Kraska","year":"2011","unstructured":"Kraska, A. et al. Age-associated cerebral atrophy in mouse lemur primates. Neurobiol Aging 32, 894\u2013906 (2011).","journal-title":"Neurobiol Aging"},{"key":"BFsrep00910_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.exger.2006.09.013","volume":"42","author":"JL Picq","year":"2007","unstructured":"Picq, J. L. Aging affects executive functions and memory in mouse lemur primates. Exp Gerontol 42, 223\u2013232 (2007).","journal-title":"Exp Gerontol"},{"key":"BFsrep00910_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0197-4580(00)00098-1","volume":"21","author":"M Dhenain","year":"2000","unstructured":"Dhenain, M. et al. MRI description of cerebral atrophy in mouse lemur primates. Neurobiol Aging 21, 81\u201388 (2000).","journal-title":"Neurobiol Aging"},{"key":"BFsrep00910_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0197-4580(98)00005-0","volume":"19","author":"M Dhenain","year":"1998","unstructured":"Dhenain, M. et al. Cerebral T2-weighted signal decrease during aging in the mouse lemur primate reflects iron accumulation. Neurobiol Aging 19, 65\u201369 (1998).","journal-title":"Neurobiol Aging"},{"key":"BFsrep00910_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0079-6123(10)83007-9","volume":"183","author":"A Oueslati","year":"2010","unstructured":"Oueslati, A., Fournier, M. & Lashuel, H. A. Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies. Prog Brain Res 183, 115\u2013145 (2010).","journal-title":"Prog Brain Res"},{"key":"BFsrep00910_CR16","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281, 29739\u201329752 (2006).","journal-title":"J Biol Chem"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep00910","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep00910.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep00910.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T04:24:53Z","timestamp":1672979093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep00910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,30]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,12,21]]}},"alternative-id":["BFsrep00910"],"URL":"https:\/\/doi.org\/10.1038\/srep00910","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,30]]},"assertion":[{"value":"31 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EB is Chief Scientific Officer of Motac neuroscience Ltd. All other authors reported no biomedical financial interests or potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"910"}}